
Scottish Medicines Consortium approves the uses of long-lasting, injectable PrEP
The Scottish Medicines Consortium (SMC) has today, 10 February 2025, announced that Cabotegravir (Apretude), a type of long-lasting, injectable, pre-exposure prophylaxis (PrEP), has been approved for...